Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income	$ 3,300,000,000	$ 621,000,000
Loss from discontinued operations	1,000,000	40,000,000
Noncash revenues, expenses, gains and losses included in income (loss):
Net gains on sales of securities available for sale and other assets	(600,000,000)	(71,000,000)
Net (gain) loss on sale of divested businesses	4,000,000	(35,000,000)
Losses on extinguishment of debt	13,000,000	10,000,000
Unrealized (gains) losses in earnings - net	(273,000,000)	601,000,000
Equity in loss from equity method investments, net of dividends or distributions	90,000,000	141,000,000
Depreciation and other amortization	3,833,000,000	3,813,000,000
Impairments of assets	237,000,000	269,000,000
Changes in operating assets and liabilities:
Insurance reserves	(2,146,000,000)	96,000,000
Premiums and other receivables and payables - net	(42,000,000)	968,000,000
Reinsurance assets and funds held under reinsurance treaties	(1,200,000,000)	(2,057,000,000)
Capitalization of deferred policy acquisition costs	(4,181,000,000)	(4,366,000,000)
Current and deferred income taxes - net	757,000,000	224,000,000
Other, net	(582,000,000)	(292,000,000)
Total adjustments	(4,090,000,000)	(699,000,000)
Net cash used in operating activities	(789,000,000)	(38,000,000)
Sales or distribution of:
Available for sale securities	17,498,000,000	18,103,000,000
Other securities	5,230,000,000	3,258,000,000
Other invested assets	3,345,000,000	3,799,000,000
Divested businesses, net	2,000,000	10,000,000
Maturities of fixed maturity securities available for sale	18,165,000,000	18,305,000,000
Principal payments received on and sales of mortgage and other loans receivable	4,233,000,000	3,068,000,000
Purchases of:
Available for sale securities	(41,612,000,000)	(32,807,000,000)
Other securities	(723,000,000)	(940,000,000)
Other invested assets	(2,662,000,000)	(2,263,000,000)
Mortgage and other loans receivable	(6,512,000,000)	(7,918,000,000)
Acquisition of businesses, net of cash and restricted cash acquired	0	(5,052,000,000)
Net change in short-term investments	(4,586,000,000)	2,411,000,000
Other, net	2,829,000,000	(891,000,000)
Net cash used in investing activities	(4,793,000,000)	(917,000,000)
Proceeds from (payments for)
Policyholder contract deposits	17,297,000,000	18,150,000,000
Policyholder contract withdrawals	(12,474,000,000)	(13,004,000,000)
Issuance of long-term debt	2,564,000,000	4,059,000,000
Repayments of long-term debt	(2,421,000,000)	(2,788,000,000)
Issuance of preferred stock	485,000,000	0
Purchase of common stock	0	(994,000,000)
Dividends paid on preferred stock	(15,000,000)	0
Dividends paid on common stock	(835,000,000)	(858,000,000)
Other, net	1,354,000,000	(3,232,000,000)
Net cash provided by financing activities	5,955,000,000	1,333,000,000
Effect of exchange rate changes on cash and restricted cash	39,000,000	8,000,000
Net increase in cash and restricted cash	412,000,000	386,000,000
Cash and restricted cash at beginning of year	3,358,000,000	2,737,000,000
Cash and restricted cash at end of period	$ 3,770,000,000	$ 3,123,000,000